Sarine Markossian
Editor-in-Chief, Assay Guidance Manual (AGM) and Lead, AGM Translational Science Resources Program, NCATS/NIH
Sarine Markossian is listed as Editor-in-Chief, Assay Guidance Manual (AGM) and Lead, AGM Translational Science Resources Program, NCATS/NIH. Sarine is scheduled to speak at SLAS 2027 International Conference & Exhibition on 30 January 2027.
Compiled from published conference agendas; not yet confirmed by Sarine. Is this you? Claim this profile.
About
Dr. Sarine Markossian is the lead of the Assay Guidance Manual (AGM) Translational Science Resources Program at the National Center for Advancing Translational Sciences (NCATS). This program is a unique translational science initiative that aims to create and disseminate best laboratory practices, tools for data analysis, and standards for rigor in early drug discovery. In this role, Markossian serves as the editor-in-chief of the AGM eBook — a free, best-practices online resource devoted to the successful development of robust, early-stage drug discovery assays — and manages the program’s training workshops. Markossian also leads and manages multiple cross-sector collaborative research programs focused on eliminating bottlenecks in preclinical translational science including the NCATS High-throughput Screening (HTS) Ring Testing Initiative and the Nuisance Compound Tool Consortium. Her current research interests are focused on improving assay robustness and reproducibility, addressing
Upcoming
SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027
- Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Speaker · 30 January 2027
Spoke alongside
People who have shared a session with Sarine at events on B2DB.
- Benjamin Bader Director / Head of Screening · Nuvisan 1 shared session
- Jayme Dahlin Medical Director, Clinical Development · Oruka Therapeutics 1 shared session
- Joe Trask Life Sciences Segment Manager, NA · Revvity 1 shared session
- Michelle Arkin Professor, Pharm Chem; co-Director, Small Molecule Discovery Center · University of California - San Francisco 1 shared session
- Nathan Coussens Scientific Director, Molecular Pharmacology Laboratory · Frederick National Laboratory for Cancer Research 1 shared session
- Stefan Grotegut Executive Director, High-Throughput Screening · Eli Lilly and Company 1 shared session
- Terry Riss Scientific Ambassador · Promega Corporation 1 shared session
- Thomas D.Y. Chung Director, Translational Programs Outreach · Sanford Burnham Prebys Medical Discovery Institute 1 shared session